MedTrace Logo

Study of Children's Well-being After the COVID-19 Pandemic in Belgian French-speaking Primary Schools

NCT05747638 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 315

Last updated 2023-12-05

No results posted yet for this study

Summary

In order to limit the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a significant numbers of measures were taken worldwide. It has been shown that the pandemic and its consequences, such as lockdown and isolation, can have a significant long-term impact on the well-being of children.

This study follows the initial DYNAtracs study on SARS-CoV-2 transmission in primary schools. In Belgium, 2488 children and 444 school attenders in 11 primary schools of the Federation Wallonia Brussels are invited. Every participant will be invited to answer a well-being questionnaire. This study aimed to document the children and workers well-being in the primary schools of Belgium after the COVID-19 pandemic. The results of the study should contribute to improved decision making regarding measures for schools and children well-being in the context of current and future pandemics.

The objective of this study is to document the well-being of children and workers after the COVID 19 pandemic in primary schools of the Federation Wallonia-Brussels.

Conditions

  • Well-being

Interventions

BEHAVIORAL

Revised Children's Manifest Anxiety Scale (RCMAS)

All participants will be invited to complete a paper questionnaire.

Sponsors & Collaborators

  • Université Catholique de Louvain

    lead OTHER

Principal Investigators

  • Annie Robert, Pr · Université Catholique de Louvain

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-14
Primary Completion
2023-06-01
Completion
2027-03-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05747638 on ClinicalTrials.gov